This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
Home
>
Cardiovascular
Cardiovascular
Candesartan for the treatment of heart failure
Immunosuppressants in cardiac transplantation
Combination therapy for global lipid improvement
ARBs for the treatment of cardiovascular diseases
VALUE: new data in hypertension treatment
Thrombolysis in acute myocardial infarction
VALUE: valsartan in hypertensive patients
The pharmacist’s role in a stroke unit
The Val-HeFT trial in an updated context
Use of Ang-II antagonists in ISH: the Val-Syst study
Val-HeFT: the Valsartan Heart Failure Trial
Managing pulmonary arterial hypertension
« Previous
1
…
67
68
69
70
71
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: